Skip to main content
. 2016 Jul 21;22(27):6257–6267. doi: 10.3748/wjg.v22.i27.6257

Table 3.

ORs and 95%CIs of gastric cancer by tertiles of dietary vitamin C

Range (mg/d) No. of controls/cases Model I OR (95%CI) Model II OR (95%CI) Model III OR (95%CI)
Total (n = 1245)
T1 < 80.14 276/186 1 1 1
T2 80.14-120.67 277/130 0.70 (0.53-0.92) 0.81 (0.59-1.10) 0.81 (0.58-1.12)
T3 ≥ 120.67 277/99 0.53 (0.40-0.71) 0.64 (0.46-0.88) 0.71 (0.50-1.00)
P for trend1 < 0.001 0.007 0.052
Men (n = 810)
T1 < 73.18 180/107 1 1 1
T2 73.18-110.59 180/93 0.87 (0.62-1.23) 1.11 (0.75-1.64) 1.07 (0.70-1.61)
T3 ≥ 110.59 180/70 0.65 (0.45-0.94) 0.78 (0.52-1.18) 0.91 (0.59-1.41)
P for trend 0.022 0.229 0.659
Women (n = 435)
T1 < 91.70 96/69 1 1 1
T2 91.70-139.52 97/45 0.65 (0.40-1.03) 0.81 (0.48-1.36) 0.85 (0.49-1.48)
T3 ≥ 139.52 97/31 0.45 (0.27-0.74) 0.57 (0.32-1.00) 0.61 (0.34-1.12)
P for trend 0.002 0.051 0.109
1

Trends were calculated using the median intake for each dietary vitamin C category as a continuous variable: Model I: Unadjusted; Model II: Adjusted by first-degree family history of gastric cancer, education level, job, household income, smoking status, regular exercise; Model III: Additionally adjusted for H. pylori infection.